[Jump to start of article]

Home > BTUH Publications > Department Papers

Articles published by the Department of Oncology

These are articles published by this Directorate of the Basildon and Thurrock University Hospitals (BTUH).

The articles are in year order the latest first. To change the sort order press one of these buttons.

Authors highlighted in bold either work for or have worked for BTUH.

Publications


2017Adding Celecoxib With or Without Zoledronic Acid for Hormone-Na´ve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.~Tsang DMason MD, Clarke NW, James ND, Dearnaley DP, Spears MR, Ritchie AW, Attard G, Cross W, Jones RJ, Parker CC, Russell JM, Thalmann GN, Schiavone F, Cassoly E, Matheson D, Millman R, Rentsch CA, Barber J, Gilson C, Ibrahim A, Logue J, Lydon A, Nikapota AD, O'Sullivan JM, Porfiri E, Protheroe A, Srihari NN, Tsang D, Wagstaff J, Wallace J, Walmsley C, Parmar MK, Sydes MR; STAMPEDE Investigators. Adding Celecoxib With or Without Zoledronic Acid for Hormone-Na´ve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial. J Clin Oncol. 2017 Mar 13:JCO2016690677. Link to item
2016Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.~Tsang DJames ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet. 2016 Mar 19;387(10024):1163-77. Link to item
2016Differentiation between Melanin-Laden Macrophages and Melanoma Cells in Vitreous Aspirates.YIakovlev EIakovlev E, Ghorab Z, Krema H, Iakovlev V, Kertes P, Yucel Y. Differentiation between Melanin-Laden Macrophages and Melanoma Cells in Vitreous Aspirates. Acta Cytol. 2016;60(1):25-30. Link to item

Disclaimer

Basildon Healthcare Library is not responsible for the content of external sites. No responsibility can be accepted for any action taken on the basis of information found on these sites.